Commentary on “Apabetalone, a BET protein inhibitor, inhibits kidney damage in diabetes by preventing pyroptosis via modulating the P300/H3K27ac/PLK1 axis”
Kaiqing Li,
Xue Xia,
Tong Fu,
Ying Tong
Affiliations
Kaiqing Li
Heilongjiang University of Chinese Medicine, Harbin, China
Xue Xia
Heilongjiang University of Chinese Medicine, Harbin, China
Tong Fu
Brandeis University, Waltham, MA, United States
Ying Tong
Corresponding author.; First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, China
